Financials
- Market Capitalization 3.74 B
- Employee 100
- Founded 2019
- CEO N/A
- Website www.newamsterdampharma.com
- Headquarter Netherlands
- FIGI N/A
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-17.98
ratio cours/chiffre d'affaires
168.78
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1535 | CPRX Catalyst Pharmaceuticals, Inc. - Common Stock | 31.49 USD | 0.00% | +0.06% | +0.41% | +48.47% | 3.85 B USD | ||
| 1540 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.29 USD | +2.45% | -3.67% | +16.87% | +78.92% | 3.82 B USD | ||
| 1552 | RLAY Relay Therapeutics, Inc. - Common Stock | 19.51 USD | +2.25% | -0.96% | +28.36% | +433.06% | 3.74 B USD | ||
| 1566 | ADPT Adaptive Biotechnologies Corporation - Common Stock | 22.90 USD | +6.86% | +12.31% | +36.31% | +32.68% | 3.67 B USD |